Beirne Wealth Consulting Services’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$141K Hold
15,000
0.03% 101
2026
Q1
$122K Hold
15,000
0.03% 103
2025
Q4
$101K Hold
15,000
0.03% 105
2025
Q3
$130K Buy
15,000
+5,000
+50% +$38.9K 0.03% 225
2025
Q2
$63K Hold
10,000
0.02% 102
2025
Q1
$64.1K Sell
10,000
-6,500
-39% -$53.7K 0.02% 101
2024
Q4
$133K Buy
16,500
+6,500
+65% +$62.7K 0.05% 96
2024
Q3
$126K Buy
+10,000
New +$129K 0.04% 100
2022
Q2
Sell
-3,150
Closed -$232K 105
2022
Q1
$232K Buy
+3,150
New +$281K 0.13% 84
2021
Q4
Sell
-1,200
Closed -$249K 117
2021
Q3
$249K Sell
1,200
-700
-37% -$154K 0.14% 86
2021
Q2
$404K Buy
1,900
+700
+58% +$128K 0.22% 63
2021
Q1
$218K Buy
+1,200
New +$239K 0.13% 87
2020
Q3
Sell
-22,250
Closed -$1.85M 143
2020
Q2
$1.85M Sell
22,250
-37,750
-63% -$1.44M 1.51% 18
2020
Q1
$815K Buy
60,000
+11,250
+23% +$95.2K 0.88% 24
2019
Q4
$194K Buy
48,750
+2,250
+5% +$9.76K 0.17% 87
2019
Q3
$233K Buy
+46,500
New +$254K 0.19% 113
2019
Q2
Sell
-7,750
Closed -$85K 175
2019
Q1
$85K Buy
7,750
+6,750
+675% +$213K 0.07% 182
2018
Q4
$37K Buy
+1,000
New +$38.8K 0.03% 176

Other funds holding NVAX

Beirne Wealth Consulting Services's NVAX Position: Q2 2026 in Review

Beirne Wealth Consulting Services held its Novavax (NVAX) position steady in Q2 2026 at 15,000 shares worth $141K. The position accounts for 0.03% of the portfolio, ranked #101.

Beirne Wealth Consulting Services first reported a position in NVAX in Q4 2018 and has held it in 18 quarters since. The position peaked at $1.85M in Q2 2020. 64 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Beirne Wealth Consulting Services held 15,000 shares of Novavax worth $141K as of Q2 2026.
  • Beirne Wealth Consulting Services left its Novavax share count unchanged in Q2 2026.
  • Novavax made up 0.03% of Beirne Wealth Consulting Services's portfolio in Q2 2026, its #101 holding.
  • Beirne Wealth Consulting Services first reported a position in Novavax in Q4 2018 and has held it in 18 quarters since.
  • Beirne Wealth Consulting Services's Novavax position peaked at $1.85M in Q2 2020.
  • 64 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Beirne Wealth Consulting Services's 13F filing for Q2 2026, filed 15 Jul 2026.